Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Parasitol ; 228: 160-166, 2016 Sep 15.
Article in English | MEDLINE | ID: mdl-27692319

ABSTRACT

Fasciolosis, a parasitic disease caused by the trematode Fasciola hepatica underreported is expanding both in human and animal population, throughout the world. The constant use of synthetic drugs to treat this condition has led to the natural selection of resistant strains of the parasite. Hence, there is a growing focus on the potential anti-helminthic properties of medicinal plants and phytopharmaceuticals. The current study assessed the potential anti-fasciolicide action of Momordica charantia leaf extracts and fractions on the eggs of F. hepatica parasites. The lyophilized crude extract (CE) of M. charantia leaves and its sub-fractions, obtained from liquid-liquid partitioning with organic solvents, were analysed by High Performance Liquid Chromatography (HPLC), suspended in 1% DMSO and used in in vitro tests. Quadruplicates of 50F. hepatica eggs were incubated at 23°C with M. charantia leaf CE in different concentrations. After 12days no larvae were formed in eggs incubated with CE concentrations above 12.5mg/mL. Eggs incubated with CE sub-fractions at concentrations of 1000, 100, 10, 1, 0.1, 0.01µg/mL affected embryonic development, with n-butanol presenting the strongest inhibition of miracidia formation. In contrast, on the 12th day, 90% of the miracidia hatched in the control experiments using 0.03% DMSO whereas embryogenesis was completely abolished with any concentration of albendazole sulphoxide ABZ(SO). Chemical analysis of the CE and sub-fractions revealed a prominent presence of flavonoids. HPLC-MS confirmed Quercetin to be one of the main flavonoids present in the CE and the n-butanol subfraction. This is the first study to analyse the potential anti-fasciolicide action of M. charantia leaf CE and subfractions.


Subject(s)
Anthelmintics/pharmacology , Cattle Diseases/drug therapy , Fasciola hepatica/drug effects , Fascioliasis/veterinary , Flavonoids/pharmacology , Momordica charantia/chemistry , Albendazole/analogs & derivatives , Albendazole/pharmacology , Animals , Cattle , Cattle Diseases/parasitology , Chromatography, High Pressure Liquid/veterinary , Fasciola hepatica/embryology , Fascioliasis/drug therapy , Fascioliasis/parasitology , Feces/parasitology , Female , Flavonoids/chemistry , Flavonoids/isolation & purification , Ovum/drug effects , Parasite Egg Count , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Leaves/chemistry , Plants, Medicinal , Quercetin/chemistry , Quercetin/isolation & purification , Quercetin/pharmacology
2.
Infect Immun ; 73(4): 2515-23, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15784598

ABSTRACT

In human schistosomiasis, the concentrations of the chemokine macrophage inflammatory protein 1alpha (MIP-1alpha/CCL3) is greater in the plasma of patients with clinical hepatosplenic disease. The objective of the present study was to confirm the ability of CCL3 to detect severe disease in patients classified by ultrasonography (US) and to evaluate the potential role of CCL3 in Schistosoma mansoni-infected mice. CCL3 was measured by enzyme-linked immunosorbent assay in the plasma of S. mansoni-infected patients. CCL3-deficient mice were infected with 25 cercariae, and various inflammatory and infectious indices were evaluated. The concentration of CCL3 was higher in the plasma of S. mansoni-infected than noninfected patients. Moreover, CCL3 was greater in those with US-defined hepatosplenic than with the intestinal form of the disease. In CCL3-deficient mice, the size of the granuloma and the liver eosinophil peroxidase activity and collagen content were diminished compared to wild-type mice. In CCL3-deficient mice, the worm burden after 14 weeks of infection, but not after 9 weeks, was consistently smaller. The in vitro response of mesenteric lymph node cells to antigen stimulation was characterized by lower levels of interleukin-4 (IL-4) and IL-10. CCL3 is a marker of disease severity in infected humans, and experimental studies in mice suggest that CCL3 may be a causative factor in the development of severe schistosomiasis.


Subject(s)
Macrophage Inflammatory Proteins/physiology , Schistosomiasis mansoni/etiology , Animals , Chemokine CCL3 , Chemokine CCL4 , Chronic Disease , Collagen/biosynthesis , Cytokines/biosynthesis , Eosinophil Peroxidase/metabolism , Female , Humans , Intestines/pathology , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...